Table 6

Prevalence of AF detected by SL-ECG or self-reported by participants

 Age (years)
All (n=13 122) (3731 M; 9357 F)<55 (n=2492) (670 M; 1822 F)55–59 (n=1412) (311 M; 1101 F)60–64 (n=1927) (460 M; 1467 F)65–69 (n=2273) (690 M; 1583 F)70–74 (n=1778) (574 M; 1204 F)75–79 (n=1628) (538 M; 1090 F)≥80 (n=1578) (488 M; 1090 F)
M
 No. of participants with AF39524153871709582
 Prevalence rate (%)10.63.64.88.310.312.217.716.8
 95% CI (%)9.6 to 11.62.2 to 5.02.4 to 7.25.8 to 10.88.0 to 12.69.5 to 14.914.5 to 20.913.5 to 20.1
F
 No. of participants with AF716566089119122118149
 Prevalence rate (%)7.63.15.46.17.510.110.813.7
 95% CI (%)7.1 to 8.12.3 to 3.94.1 to 6.74.9 to 7.36.2 to 8.89 to 11.89 to 12.611.7 to 15.7
Total
 No. of participants with AF11118075127190192213231
 Prevalence rate (%)8.53.25.36.68.410.813.114.6
 95% CI (%)8 to 92.5 to 3.94.1 to 6.55.5 to 7.77.3 to 9.59.4 to 12.211.5 to 14.712.9 to 16.3
  • AF, atrial fibrillation; F, female; M, male; SL-ECG, wireless single-lead ECG.